
|Videos|October 16, 2017
What Unique Challenges Does AllianceRx Walgreens Prime Face?
Joel Wright, chief executive officer, Alliance Rx Walgreens Prime discusses challenges associated with combining specialty pharmacy operations.
Advertisement
Wright: We are a new company that combines the specialty pharmacies from Prime Therapeutics and Walgreens Specialty Pharmacy. So, our challenges are around how do we bring these 2 strong models together and pick the best of each piece and utilize the best pieces of the platform.
Of course, any specialty pharmacy that were to launch has limited distribution networks to navigate, payer networks to navigate, as well as all of the adherence [challenges]—we are in a highly regulated environment—and to make sure we are actually driving value in that space.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Medicare Is Finally Covering GLP-1s for Weight Loss: What the Bridge Program Means for Your Practice
2
Beyond Injections: The Rise of Oral GLP-1 Therapy
3
FAQs Amid the Ongoing US Measles Outbreaks
4
ADA 2026: Diabetes Technology Innovations Expand Beyond Traditional CGM Use
5



















































































































